PONO vs. BNR, ABLV, MTC, RR, BGSF, CNGL, AIXI, RCAT, KPLT, and ALLT
Should you be buying Pono Capital stock or one of its competitors? The main competitors of Pono Capital include Burning Rock Biotech (BNR), Able View Global (ABLV), MMTec (MTC), Richtech Robotics (RR), BGSF (BGSF), Canna-Global Acquisition (CNGL), Xiao-I (AIXI), Red Cat (RCAT), Katapult (KPLT), and Allot Communications (ALLT). These companies are all part of the "business services" sector.
Burning Rock Biotech (NASDAQ:BNR) and Pono Capital (NASDAQ:PONO) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership, community ranking and risk.
In the previous week, Burning Rock Biotech had 7 more articles in the media than Pono Capital. MarketBeat recorded 7 mentions for Burning Rock Biotech and 0 mentions for Pono Capital. Pono Capital's average media sentiment score of 0.75 beat Burning Rock Biotech's score of 0.00 indicating that Burning Rock Biotech is being referred to more favorably in the media.
Burning Rock Biotech has a beta of 0.18, meaning that its share price is 82% less volatile than the S&P 500. Comparatively, Pono Capital has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500.
Pono Capital has lower revenue, but higher earnings than Burning Rock Biotech.
Pono Capital has a net margin of 0.00% compared to Pono Capital's net margin of -121.79%. Burning Rock Biotech's return on equity of 0.00% beat Pono Capital's return on equity.
30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 74.1% of Pono Capital shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Burning Rock Biotech received 5 more outperform votes than Pono Capital when rated by MarketBeat users.
Summary
Burning Rock Biotech beats Pono Capital on 6 of the 11 factors compared between the two stocks.
Get Pono Capital News Delivered to You Automatically
Sign up to receive the latest news and ratings for PONO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PONO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Pono Capital Competitors List
Related Companies and Tools
